Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Avalo Therapeutics (AVTX) Gross Profit (2017 - 2024)

Avalo Therapeutics' Gross Profit history spans 8 years, with the latest figure at -$465000.0 for Q3 2024.

  • For Q3 2024, Gross Profit fell 4127.27% year-over-year to -$465000.0; the TTM value through Sep 2024 reached -$96000.0, down 177.42%, while the annual FY2023 figure was $640000.0, 95.62% down from the prior year.
  • Gross Profit reached -$465000.0 in Q3 2024 per AVTX's latest filing, down from -$343000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $14.4 million in Q3 2022 to a low of -$534000.0 in Q2 2022.
  • Average Gross Profit over 5 years is $1.2 million, with a median of $276000.0 recorded in 2022.
  • Peak YoY movement for Gross Profit: soared 4183.08% in 2020, then crashed 4127.27% in 2024.
  • A 5-year view of Gross Profit shows it stood at $1.4 million in 2020, then tumbled by 114.46% to -$205000.0 in 2021, then surged by 234.63% to $276000.0 in 2022, then soared by 186.96% to $792000.0 in 2023, then plummeted by 158.71% to -$465000.0 in 2024.
  • Per Business Quant, the three most recent readings for AVTX's Gross Profit are -$465000.0 (Q3 2024), -$343000.0 (Q2 2024), and -$80000.0 (Q1 2024).